Crohn Colitis
12
2
2
3
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
8.3%
1 terminated out of 12 trials
75.0%
-11.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (12)
Study of Mesenchymal Stem Cells for the Treatment of Medically Refractory Crohn's Colitis
High Definition Colonoscopy (HDC) vs. Dye Spraying Chromo-colonoscopy (DSC) in Screening Patients With Long-standing Inflammatory Bowel Disease (IBD)
Personalized Risk Estimation for Crohn's Disease (PRE-Crohn's): Implementation and Feasibility
A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease
A Pilot Study to Explore the Role of Gut Flora in Crohn's Disease
Investigating the Anti-inflammatory Effects of Frondanol in Adults With Inflammatory Bowel Disease
Investigation of VAP-1 Expression and Tissue Blood Flow by PET-MRI in Patients With Crohn's Disease
The Mind-Body IBD Study: Understanding the Mind-body Connection in IBD
Evaluate Established Anti-DEFA5 mAbs Diagnostic Efficacy and Safety in IBD
OPtical Diagnosis Training to Improve Dysplasia Characterisation in IBD
Objective Perfusion Rate Assessment by Near-infrared Fluorescence in Ileal Pouch Formation and Ileal-pouch-anal Anastomosis
Subjective Near-infrared Fluorescence Guidance in Perfusion Assessment of Ileal Pouch Formation and Ileal-pouch-anal Anastomosis